haloperidol has been researched along with carbamates in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shirasu, Y; Takahashi, H; Tanaka, J; Tsuda, S | 1 |
Fawcett, CP; Kalra, PS; Kalra, SP; Krulich, L; McCann, SM | 1 |
Brown, PS; Choudhury, SA; Sharpe, RM | 1 |
Harcup, M; Jain, VK; Magowan, S; Tewfik, GI | 1 |
Bouillaguet, S; Galgano, C; Golay, A; Krejci, I; Lockwood, PE; Wataha, JC | 1 |
Mikkelsen, JD | 1 |
Boelaarts, L; de Jonghe, JF; Hovinga, IM; Kalisvaart, CJ; Kat, MG | 1 |
Ebbesen, C; Hansen, HH; Mathiesen, C; Mikkelsen, JD; Rønn, LC; Scuvée-Moreau, J; Seutin, V; Waroux, O; Weikop, P | 1 |
Hansen, HH; Mikkelsen, JD; Mikkelsen, MD; Rode, F; Weikop, P | 1 |
Gotoh, H; Hayashi, Y; Ishikawa, H; Masui, R | 1 |
1 trial(s) available for haloperidol and carbamates
Article | Year |
---|---|
Effectiveness of various tranquilisers in the management of senile restlessness.
Topics: Aged; Carbamates; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; Hyperkinesis; Male; Middle Aged; Oxazepam; Placebos; Thioridazine; Tranquilizing Agents | 1970 |
9 other study(ies) available for haloperidol and carbamates
Article | Year |
---|---|
Contribution of monoaminergic nervous system in potentiation of 2-sec-butylphenyl N-methylcarbamate (BPMC) toxicity by malathion in male mice.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Carbamates; Drug Synergism; Haloperidol; Insecticides; Malathion; Male; Mice; Nervous System; Reserpine | 1987 |
Involvement of norepinephrine in transmission of the stimulatory influence of progesterone on gonadotropin release.
Topics: Animals; Carbamates; Catecholamines; Catechols; Chelating Agents; Dihydroxyphenylalanine; Dopamine; Estradiol; Female; Fenclonine; Follicle Stimulating Hormone; Haloperidol; Luteinizing Hormone; Methyltyrosines; Norepinephrine; Oxidoreductases; Phenoxybenzamine; Progesterone; Propranolol; Rats; Serine; Serotonin; Time Factors | 1972 |
Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
Topics: Animals; Apomorphine; Carbamates; Catecholamines; Chorionic Gonadotropin; Clonidine; Depression, Chemical; Dihydroxyphenylalanine; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Female; Follicle Stimulating Hormone; Haloperidol; Male; Methyltyrosines; Norepinephrine; Organ Size; Ovary; Phenoxybenzamine; Pimozide; Pituitary Gland; Rats; Receptors, Drug; Stimulation, Chemical | 1973 |
Cytotoxicity and sealing properties of four classes of endodontic sealers evaluated by succinic dehydrogenase activity and confocal laser scanning microscopy.
Topics: Analysis of Variance; Animals; BALB 3T3 Cells; Carbamates; Coloring Agents; Composite Resins; Dental Bonding; Dental Cements; Dental Leakage; Epoxy Resins; Fluorescent Dyes; Humans; Lipopolysaccharides; Materials Testing; Mice; Microscopy, Confocal; Polyesters; Rhodamines; Root Canal Filling Materials; Root Canal Obturation; Succinate Dehydrogenase; Surface Properties; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat.
Topics: Animals; Anticonvulsants; Carbamates; Cell Count; Corpus Striatum; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Gene Expression Regulation; Haloperidol; Immunohistochemistry; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Phenylenediamines; Potassium Channels; Potassium Channels, Voltage-Gated; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar | 2004 |
[Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Delirium; Haloperidol; Hospitalization; Humans; Male; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2004 |
The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
Topics: Animals; Anthracenes; Carbamates; Dopamine; Dopamine Antagonists; Haloperidol; KCNQ Potassium Channels; Male; Mesencephalon; Phenylenediamines; Phosphorylation; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
Topics: Animals; Anticonvulsants; Biomarkers; Carbamates; Corpus Striatum; Cortical Excitability; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Haloperidol; Injections, Intraventricular; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Nerve Tissue Proteins; Neurons, Afferent; Neurons, Efferent; Nucleus Accumbens; Phenylenediamines; Protein Subunits; Proto-Oncogene Proteins c-fos; Rats, Wistar; Synaptic Transmission | 2017 |
Diphenylprolinol silyl ether as a catalyst in an enantioselective, catalytic, formal aza [3+3] cycloaddition reaction for the formation of enantioenriched piperidines.
Topics: Aldehydes; Aza Compounds; Carbamates; Catalysis; Cyclization; Ethers; Molecular Structure; Piperidines; Proline; Stereoisomerism | 2008 |